# Oramed Pharmaceuticals Inc.: Form 8-K, filed Nov 4, 2021

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2021-11-04
- Accepted by EDGAR: Nov 4, 2021, 17:17 ET
- Period: 2021-11-03
- Accession: 0001213900-21-056803
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390021056803/ea149991-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390021056803/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390021056803/ea149991-8k_oramed.htm

Filed Nov 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-056803. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
